The protective response we observed during miR-133a overexpression during diabetes involves down-regulation of TGF-β1 and decreased phosphorylation of SMAD2 and reduced ERK1/2 activation (Fig. 5 Summary Diagram). This evidence concerns the gene TGFB1 and diabetes mellitus.